BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: DuBroff R, de Lorgeril M. Cholesterol confusion and statin controversy. World J Cardiol 2015; 7(7): 404-409 [PMID: 26225201 DOI: 10.4330/wjc.v7.i7.404]
URL: https://www.wjgnet.com/1949-8462/full/v7/i7/404.htm
Number Citing Articles
1
Yang Wang, Jinsong Wang, Shenming Wang. Comparative Effectiveness of Inclisiran 100, 300, and 500 mg in a Population with Hyperlipidemia: A Network Meta-Analysis of Randomized Controlled TrialsAmerican Journal of Cardiovascular Drugs 2018; 18(4): 271 doi: 10.1007/s40256-018-0270-7
2
Nikolaos Tzenios, Erin D. Lewis, David C. Crowley, Mohamad Chahine, Malkanthi Evans. Examining the Efficacy of a Very-Low-Carbohydrate Ketogenic Diet on Cardiovascular Health in Adults with Mildly Elevated Low-Density Lipoprotein Cholesterol in an Open-Label Pilot StudyMetabolic Syndrome and Related Disorders 2022; 20(2): 94 doi: 10.1089/met.2021.0042
3
Onkar Bedi, Veena Dhawan, P. L. Sharma, Puneet Kumar. Pleiotropic effects of statins: new therapeutic targets in drug designNaunyn-Schmiedeberg's Archives of Pharmacology 2016; 389(7): 695 doi: 10.1007/s00210-016-1252-4
4
Shun Tanimura, Mutsumi Nishida, Tatsunori Horie, Tamotsu Kamishima, Hitomi Matsumoto, Yutaka Morimura, Yuka Nishibata, Sakiko Masuda, Daigo Nakazawa, Utano Tomaru, Tatsuya Atsumi, Akihiro Ishizu. Fluvastatin prevents the development of arthritis in env-pX rats via up-regulation of Rho GTPase-activating protein 12Experimental and Molecular Pathology 2020; 115: 104454 doi: 10.1016/j.yexmp.2020.104454
5
Monika Kopec, Karolina Beton-Mysur, Halina Abramczyk. Raman imaging and chemometric methods in human normal bronchial and cancer lung cells: Raman biomarkers of lipid reprogrammingChemistry and Physics of Lipids 2023; 257: 105339 doi: 10.1016/j.chemphyslip.2023.105339
6
Dong-Hyeon Lee, Ho-Joong Youn, Hae-Ok Jung, Kiyuk Chang, Yun-Seok Choi, Jung Im Jung. Coronary artery calcium score plays an important role for cardiovascular risk stratification in the statin benefit groups of asymptomatic individualsLipids in Health and Disease 2017; 16(1) doi: 10.1186/s12944-017-0560-0
7
Liang Gu, Sourav Taru Saha, Jodie Thomas, Mandeep Kaur. Targeting cellular cholesterol for anticancer therapyThe FEBS Journal 2019; 286(21): 4192 doi: 10.1111/febs.15018
8
Daniel A. Hofmaenner, Anna Kleyman, Adrian Press, Michael Bauer, Mervyn Singer. The Many Roles of Cholesterol in Sepsis: A ReviewAmerican Journal of Respiratory and Critical Care Medicine 2022; 205(4): 388 doi: 10.1164/rccm.202105-1197TR
9
Alexander N Kharlamov. Why do we fail to achieve Glagovian atheroregression in lipid-lowering trials?Interventional Cardiology 2015; 7(5): 469 doi: 10.2217/ica.15.37
10
Axel Haverich, Erin Colleen Boyle. Atherosclerosis Pathogenesis and Microvascular Dysfunction2019; : 9 doi: 10.1007/978-3-030-20245-3_2
11
Afshin Amirpoor, Reihaneh Zavar, Atefeh Amerizadeh, Sedigheh Asgary, Sajjad Moradi, Mohammad Hosein Farzaei, Gholamreza Masoumi, Masoumeh Sadeghi. Effect of Beetroot Consumption on Serum Lipid Profile: A Systematic Review and Meta-AnalysisCurrent Problems in Cardiology 2022; 47(7): 100887 doi: 10.1016/j.cpcardiol.2021.100887
12
David M. Diamond, Michel de Lorgeril, Malcolm Kendrick, Uffe Ravnskov, Paul J. Rosch, Hajo Zeeb. Formal comment on “Systematic review of the predictors of statin adherence for the primary prevention of cardiovascular disease”PLOS ONE 2019; 14(1): e0205138 doi: 10.1371/journal.pone.0205138
13
Azhar Hussain, Jasndeep Kaler, Sidhartha D Ray. The Benefits Outweigh the Risks of Treating Hypercholesterolemia: The Statin DilemmaCureus 2023;  doi: 10.7759/cureus.33648
14
Alexander N. Kharlamov. Scaffold thrombosis: Exaggerated illusion, or when statistics rulesInternational Journal of Cardiology 2016; 209: 206 doi: 10.1016/j.ijcard.2016.02.054
15
D. M. Aronov, M. G. Bubnova, O. M. Drapkina. Atherosclerosis pathogenesis from the perspective of microvascular dysfunctionCardiovascular Therapy and Prevention 2021; 20(7): 3076 doi: 10.15829/1728-8800-2021-3076
16
Rosa Vona, Elisabetta Iessi, Paola Matarrese. Role of Cholesterol and Lipid Rafts in Cancer Signaling: A Promising Therapeutic Opportunity?Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.622908
17
Maryanne Demasi. Statin wars: have we been misled about the evidence? A narrative reviewBritish Journal of Sports Medicine 2018; 52(14): 905 doi: 10.1136/bjsports-2017-098497
18
Zhenqi Liu, Baichun Yang. Drug Development Strategy for Type 2 Diabetes: Targeting Positive Energy BalancesCurrent Drug Targets 2019; 20(8): 879 doi: 10.2174/1389450120666181217111500
19
Sherif Sultan, Ashwini D'Souza, Ioannis Zabetakis, Ronan Lordan, Alexandros Tsoupras, Edel P. Kavanagh, Niamh Hynes. The Impact of Nutrition and Statins on Cardiovascular Diseases2019; : 171 doi: 10.1016/B978-0-12-813792-5.00006-9
20
Zsolt Murlasits. A call for the better utilization of physical activity and exercise training in the defense against cardiovascular diseaseThe Physician and Sportsmedicine 2015; 43(4): 329 doi: 10.1080/00913847.2015.1095618
21
Mohamed A. Jalloh, Eric J. Ip, Shadi Doroudgar. What is the impact of the 2017 cochrane systematic review and meta-analysis that evaluated the use of PCSK9 inhibitors for lowering cardiovascular disease and mortality?Expert Opinion on Pharmacotherapy 2018; 19(7): 739 doi: 10.1080/14656566.2018.1464558
22
Annette Leibing. Situated Prevention: Framing the “New Dementia”Journal of Law, Medicine & Ethics 2018; 46(3): 704 doi: 10.1177/1073110518804232
23
Elżbieta Paszek, Wojciech Zajdel, Tomasz Rajs, Krzysztof Żmudka, Jacek Legutko, Paweł Kleczyński. Profilin 1 and Mitochondria—Partners in the Pathogenesis of Coronary Artery Disease?International Journal of Molecular Sciences 2021; 22(3): 1100 doi: 10.3390/ijms22031100
24
Kun Huang, Hanjoong Jo, Jing Echesabal-Chen, Alexis Stamatikos. Combined LXR and RXR Agonist Therapy Increases ABCA1 Protein Expression and Enhances ApoAI-Mediated Cholesterol Efflux in Cultured Endothelial CellsMetabolites 2021; 11(9): 640 doi: 10.3390/metabo11090640
25
Axel Haverich, Erin Colleen Boyle. Atherosklerose-Pathogenese und mikrovaskuläre Dysfunktion2023; : 9 doi: 10.1007/978-3-031-31766-8_2
26
Qian Xu, Yiming Deng, Jun Xiao, Xiangrui Liu, Min Zhou, Zhong Ren, Juan Peng, Yaling Tang, Zhisheng Jiang, Zhihan Tang, Lushan Liu. Three Musketeers for Lowering Cholesterol: Statins, Ezetimibe and EvolocumabCurrent Medicinal Chemistry 2021; 28(5): 1025 doi: 10.2174/0929867327666200505091738
27
Dawn M. Fernandez, Jose C. Clemente, Chiara Giannarelli. Physical Activity, Immune System, and the Microbiome in Cardiovascular DiseaseFrontiers in Physiology 2018; 9 doi: 10.3389/fphys.2018.00763
28
Rumi Iqbal Doewes, Ghazal Gharibian, Firoozeh Abolhasani zadeh, Burhan Abdullah Zaman, Sahar vahdat, Reza Akhavan-Sigari. An Updated Systematic Review on the Effects of Aerobic Exercise on Human Blood Lipid ProfileCurrent Problems in Cardiology 2023; 48(5): 101108 doi: 10.1016/j.cpcardiol.2022.101108
29
Hayrettin Ozan Gulcan, Serkan Yigitkan, Ilkay Erdogan Orhan. The Natural Products as Hydroxymethylglutaryl-Coa Reductase InhibitorsLetters in Drug Design & Discovery 2019; 16(10): 1130 doi: 10.2174/1570180816666181112144353
30
Stefan Dragulinescu. Inference to the best explanation and mechanisms in medicineTheoretical Medicine and Bioethics 2016; 37(3): 211 doi: 10.1007/s11017-016-9365-9
31
Justin Tondt, William S. Yancy, Eric C. Westman. Application of nutrient essentiality criteria to dietary carbohydratesNutrition Research Reviews 2020; 33(2): 260 doi: 10.1017/S0954422420000050
32
Mazaher Ahmadi, Shayan Amiri, Stevan Pecic, Filip Machaj, Jakub Rosik, Marek J. Łos, Javad Alizadeh, Reza Mahdian, Simone C. da Silva Rosa, Dedmer Schaafsma, Shahla Shojaei, Tayyebeh Madrakian, Amir A. Zeki, Saeid Ghavami. Pleiotropic effects of statins: A focus on cancerBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2020; 1866(12): 165968 doi: 10.1016/j.bbadis.2020.165968
33
Etienne Ho Kit Mok, Terence Kin Wah Lee. The Pivotal Role of the Dysregulation of Cholesterol Homeostasis in Cancer: Implications for Therapeutic TargetsCancers 2020; 12(6): 1410 doi: 10.3390/cancers12061410
34
Shiyong Yu, Jun Jin, Zhongxiu Chen, Xiaolu Luo. High-intensity statin therapy yields better outcomes in acute coronary syndrome patients: a meta-analysis involving 26,497 patientsLipids in Health and Disease 2020; 19(1) doi: 10.1186/s12944-020-01369-6
35
Malkanthi Evans, Erin D. Lewis, Joseph M. Antony, David C. Crowley, Andrew Charrette, Najla Guthrie, Jeffrey B. Blumberg, Gregor Reid. Revisiting the Definition of ‘Healthy’ Participants in Substantiation of Structure/Function Claims for Dietary SupplementsJournal of Dietary Supplements 2024; : 1 doi: 10.1080/19390211.2023.2301383
36
Jacques Blacher. L’hypertension artérielle en France, une situation préoccupante : une réplique du tremblement de terre cholestérol/statines ?La Presse Médicale 2018; 47(6): 497 doi: 10.1016/j.lpm.2018.05.011
37
Xin Guo, Mingming Gao, Yunan Wang, Xiao Lin, Liu Yang, Nathan Cong, Xiangbo An, Feng Wang, Kai Qu, Liqing Yu, Yuhui Wang, Jinjie Wang, Haibo Zhu, Xunde Xian, George Liu. LDL Receptor Gene-ablated Hamsters: A Rodent Model of Familial Hypercholesterolemia With Dominant Inheritance and Diet-induced Coronary AtherosclerosisEBioMedicine 2018; 27: 214 doi: 10.1016/j.ebiom.2017.12.013
38
Harold Edward Bays. Alirocumab, Decreased Mortality, Nominal Significance, P Values, Bayesian Statistics, and the Duplicity of Multiplicity Circulation 2019; 140(2): 113 doi: 10.1161/CIRCULATIONAHA.119.041496
39
Aleyda Benitez‐Amaro, Chiara Pallara, Laura Nasarre, Ruben Ferreira, David de Gonzalo‐Calvo, Roger Prades, Teresa Tarragó, Vicenta Llorente‐Cortés. Development of Innovative Antiatherosclerotic Peptides through the Combination of Molecular Modeling and a Dual (Biochemical‐Cellular) Screening SystemAdvanced Therapeutics 2020; 3(8) doi: 10.1002/adtp.202000037
40
Carlo Martini, Mattia Andreoletti. Genuine versus bogus scientific controversies: the case of statinsHistory and Philosophy of the Life Sciences 2021; 43(4) doi: 10.1007/s40656-021-00456-w
41
T. Vidal-Trécan, M. Laloi-Michelin, C. Bouché, V. Juddoo, J.-G. Dillinger, I. Azancot, J.-P. Kevorkian, L. Salle, F. Feron, P. Henry, J.F. Gautier, J.-. Riveline. Can the ESC/EAS LDL-cholesterol target in patients with diabetes and high cardiovascular risk be achieved in clinical practice? Results from an ambulatory multidisciplinary diabetes center cohortDiabetes & Metabolism 2019; 45(6): 592 doi: 10.1016/j.diabet.2018.01.010
42
Kobra Bahrampour Juybari, Azam Hosseinzadeh, Ali Mohammad Sharifi. Protective effects of atorvastatin against high glucose-induced nuclear factor-κB activation in cultured C28I2 chondrocytesJournal of Receptors and Signal Transduction 2019; 39(1): 1 doi: 10.1080/10799893.2018.1557206
43
Arnoud van der Laarse, Christa M. Cobbaert. Biochemical risk factors of atherosclerotic cardiovascular disease: from a narrow and controversial approach to an integral approach and precision medicineExpert Review of Cardiovascular Therapy 2021; 19(12): 1085 doi: 10.1080/14779072.2021.2022475
44
Marija Ljubičić, Marijana Matek Sarić, Ivo Klarin, Ivana Rumbak, Irena Colić Barić, Jasmina Ranilović, Ayman EL-Kenawy, Maria Papageorgiou, Elena Vittadini, Maša Černelič Bizjak, Raquel Guiné. Motivation for health behaviour: A predictor of adherence to balanced and healthy food across different coastal Mediterranean countriesJournal of Functional Foods 2022; 91: 105018 doi: 10.1016/j.jff.2022.105018
45
Chrystyne Olivieri. The current state of heart diseaseInternational Journal of Evidence-Based Healthcare 2019; 17(3): 179 doi: 10.1097/XEB.0000000000000197
46
Waseem Hassan, Batool Ghorbani Yekta, Seyed Mohammad Nabavi, Maciej Banach, Aysa Rezabakhsh. The Progress and Research Trends of Statin Medications: Advanced Epidemiological and Bibliometrical AssessmentCurrent Problems in Cardiology 2023; 48(6): 101638 doi: 10.1016/j.cpcardiol.2023.101638